These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 23773776)

  • 1. Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?
    Ezquer F; Ezquer M; Arango-Rodriguez M; Conget P
    Acta Ophthalmol; 2014 Mar; 92(2):e86-95. PubMed ID: 23773776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice.
    Ezquer M; Urzua CA; Montecino S; Leal K; Conget P; Ezquer F
    Stem Cell Res Ther; 2016 Mar; 7():42. PubMed ID: 26983784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy.
    Fiori A; Terlizzi V; Kremer H; Gebauer J; Hammes HP; Harmsen MC; Bieback K
    Immunobiology; 2018 Dec; 223(12):729-743. PubMed ID: 29402461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perivascular Progenitor Cells Derived From Human Embryonic Stem Cells Exhibit Functional Characteristics of Pericytes and Improve the Retinal Vasculature in a Rodent Model of Diabetic Retinopathy.
    Kim JM; Hong KS; Song WK; Bae D; Hwang IK; Kim JS; Chung HM
    Stem Cells Transl Med; 2016 Sep; 5(9):1268-76. PubMed ID: 27388242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin: an efficient step forward in mesenchymal stem cell therapy of diabetic retinopathy.
    Mottaghi S; Larijani B; Sharifi AM
    Cytotherapy; 2013 Mar; 15(3):263-6. PubMed ID: 23253439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy.
    Ezquer ME; Ezquer FE; Arango-Rodríguez ML; Conget PA
    Biol Res; 2012; 45(3):289-96. PubMed ID: 23283438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief Report: Elastin Microfibril Interface 1 and Integrin-Linked Protein Kinase Are Novel Markers of Islet Regenerative Function in Human Multipotent Mesenchymal Stromal Cells.
    Lavoie JR; Creskey MM; Muradia G; Bell GI; Sherman SE; Gao J; Stewart DJ; Cyr TD; Hess DA; Rosu-Myles M
    Stem Cells; 2016 Aug; 34(8):2249-55. PubMed ID: 27090767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human inferior turbinate: an alternative tissue source of multipotent mesenchymal stromal cells.
    Hwang SH; Kim SY; Park SH; Choi MY; Kang HW; Seol YJ; Park JH; Cho DW; Hong OK; Rha JG; Kim SW
    Otolaryngol Head Neck Surg; 2012 Sep; 147(3):568-74. PubMed ID: 22588732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose-derived mesenchymal stromal cells reverse high glucose-induced reduction of angiogenesis in human retinal microvascular endothelial cells.
    Fiori A; Hammes HP; Bieback K
    Cytotherapy; 2020 May; 22(5):261-275. PubMed ID: 32247542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles derived from mesenchymal stem cells induce features of diabetic retinopathy in vitro.
    Beltramo E; Lopatina T; Berrone E; Mazzeo A; Iavello A; Camussi G; Porta M
    Acta Diabetol; 2014 Dec; 51(6):1055-64. PubMed ID: 25374383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical-grade human embryonic stem cell-derived mesenchymal stromal cells ameliorate diabetic retinopathy in db/db mice.
    Rong L; Wei W; Fang Y; Liu Y; Gao T; Wang L; Hao J; Gu X; Wu J; Wu W
    Cytotherapy; 2024 Jun; 26(6):606-615. PubMed ID: 38483364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration.
    Li F; Whyte N; Niyibizi C
    Biochem Biophys Res Commun; 2012 Oct; 426(4):475-9. PubMed ID: 22960177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis.
    Volarevic V; Nurkovic J; Arsenijevic N; Stojkovic M
    Stem Cells; 2014 Nov; 32(11):2818-23. PubMed ID: 25154380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells: misconceptions and evolving concepts.
    Phinney DG; Sensebé L
    Cytotherapy; 2013 Feb; 15(2):140-5. PubMed ID: 23321325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases.
    Ding SLS; Kumar S; Mok PL
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus.
    Hainsworth DP; Katz ML; Sanders DA; Sanders DN; Wright EJ; Sturek M
    Comp Med; 2002 Dec; 52(6):523-9. PubMed ID: 12540165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic applications of mesenchymal stromal cells.
    Brooke G; Cook M; Blair C; Han R; Heazlewood C; Jones B; Kambouris M; Kollar K; McTaggart S; Pelekanos R; Rice A; Rossetti T; Atkinson K
    Semin Cell Dev Biol; 2007 Dec; 18(6):846-58. PubMed ID: 18024097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME; Fibbe WE; Rabelink TJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
    Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
    Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.